Metabolic activity is suppressed by the mTOR inhibitor AZD2014 in FGF19-overexpressing LSQ cells, and tumor growth is inhibited in vivo, highlighting the key regulatory role of mTOR in FGF19-driven tumor metabolism 136. Here, FGF19 is linked to neoplasm.